Management paper

EntreMed Exe screwive Summary 1.1 History and Background EntreMed, Inc., Maryland founded in 1991 and publically-traded since 1996 (NASDAQ: ENMD) a clinical-stage biopharmaceutical company wee therapeutics that act on triplex electric cellular pathways tortuous in processes such as abnormal blood vas growth, inflammation, coagulation, and programmed cell death(entremed.com) through and through a combination of some(prenominal) hypermetropy and fortuity, EntreMed, in 1993, initiated its quislingism with Dr. Judah Folkman, the father of angiogenesis, who, more than 30 old age ago, ascertained that tumors were unable to thrive without networks of saucy blood vessels to establish them. The companys clinical drug candidates, led by the minute grain Panzem, pay off shown a strong safeguard profile with neither toxicity nor clinically significant berth effects reported. The important tenseness of EntreMeds drug pipeline is small molecules and peptides. Since the companys inception in kinsfolk 1991, they approach down devoted or so all of its efforts and resources to conducting query and suppuration. through December 31, 2002, all of its revenues grow been generated from license fees, query and ontogeny funding, royal family payments, the sale of royalty rights, and certain investigate grants.

EntreMed have not generated any revenue from direct ware sales, and the care anticipates that this situation will switch over in the forthcoming years because the company has nine mathematical product candidates in development and collar product candidates in gentle clinical trials. 1.2 industry and Competitors EntreMed operates in a very challenging, still also reward industry, bioengineering industry. Nearly 20 lot of the 320 US publicly traded biotech companies underwent restructuring in 2002 and more than 80 share of those restructured companies were forced to cut programs and set up of employees. On a ball-shaped basis, the net hurt of the ergonomics industry increased more or less $5.7 million to $12.4 billion as the number of public companies decreased 3 percent in 2002. The past year... If you want to get a spacious essay, devote it on our website: Orderessay

If you want to get a full information about our service, visit our page: How it works.